These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 30620509)
1. [Prediction and Personalized Medicine of Antidepressant Treatment in Japanese MDD Patient]. Kato M Seishin Shinkeigaku Zasshi; 2016; 118(3):139-146. PubMed ID: 30620509 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738 [TBL] [Abstract][Full Text] [Related]
3. Personalized medicine in major depressive disorder -- opportunities and pitfalls. Miller DB; O'Callaghan JP Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder. Cameron IM; Reid IC; MacGillivray SA J Affect Disord; 2014 Sep; 166():48-58. PubMed ID: 25012410 [TBL] [Abstract][Full Text] [Related]
6. Gene × environment interactions in the prediction of response to antidepressant treatment. Klengel T; Binder EB Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009 [TBL] [Abstract][Full Text] [Related]
7. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants]. Leblé N; Radon L; Rabot M; Godart N Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149 [TBL] [Abstract][Full Text] [Related]
8. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment]. Kato M Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):83-92. PubMed ID: 20491282 [TBL] [Abstract][Full Text] [Related]
9. Criticisms of drugs in early development for the treatment of depression: what can be improved? Wang SM; Han C; Pae CU Expert Opin Investig Drugs; 2015 Apr; 24(4):445-53. PubMed ID: 25529224 [TBL] [Abstract][Full Text] [Related]
10. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. Khin NA; Chen YF; Yang Y; Yang P; Laughren TP J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123 [TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327 [TBL] [Abstract][Full Text] [Related]
12. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression. Papakostas GI; Martinson MA; Fava M; Iovieno N J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092 [TBL] [Abstract][Full Text] [Related]
13. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001 [TBL] [Abstract][Full Text] [Related]
14. S-adenosyl-methionine in depression: a comprehensive review of the literature. Papakostas GI; Alpert JE; Fava M Curr Psychiatry Rep; 2003 Dec; 5(6):460-6. PubMed ID: 14609501 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review. Lee Y; Rosenblat JD; Lee J; Carmona NE; Subramaniapillai M; Shekotikhina M; Mansur RB; Brietzke E; Lee JH; Ho RC; Yim SJ; McIntyre RS J Affect Disord; 2018 Feb; 227():406-415. PubMed ID: 29154157 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. Levkovitz Y; Tedeschini E; Papakostas GI J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126 [TBL] [Abstract][Full Text] [Related]
17. Predicting antidepressant response using early changes in cognition: A systematic review. Park C; Pan Z; Brietzke E; Subramaniapillai M; Rosenblat JD; Zuckerman H; Lee Y; Fus D; McIntyre RS Behav Brain Res; 2018 Nov; 353():154-160. PubMed ID: 30031025 [TBL] [Abstract][Full Text] [Related]
18. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis. Pedrelli P; Iovieno N; Vitali M; Tedeschini E; Bentley KH; Papakostas GI J Clin Psychopharmacol; 2011 Oct; 31(5):582-6. PubMed ID: 21869696 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort. Fond G; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Marulaz L; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM J Affect Disord; 2019 Feb; 245():468-474. PubMed ID: 30428447 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of St. John's wort for major depressive disorder. Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]